全文获取类型
收费全文 | 17549篇 |
免费 | 1021篇 |
国内免费 | 140篇 |
专业分类
耳鼻咽喉 | 142篇 |
儿科学 | 434篇 |
妇产科学 | 366篇 |
基础医学 | 1923篇 |
口腔科学 | 510篇 |
临床医学 | 1892篇 |
内科学 | 4071篇 |
皮肤病学 | 225篇 |
神经病学 | 1814篇 |
特种医学 | 507篇 |
外科学 | 2463篇 |
综合类 | 76篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 1314篇 |
眼科学 | 355篇 |
药学 | 963篇 |
中国医学 | 22篇 |
肿瘤学 | 1620篇 |
出版年
2024年 | 14篇 |
2023年 | 143篇 |
2022年 | 291篇 |
2021年 | 555篇 |
2020年 | 315篇 |
2019年 | 517篇 |
2018年 | 553篇 |
2017年 | 452篇 |
2016年 | 433篇 |
2015年 | 513篇 |
2014年 | 755篇 |
2013年 | 932篇 |
2012年 | 1345篇 |
2011年 | 1449篇 |
2010年 | 745篇 |
2009年 | 680篇 |
2008年 | 1242篇 |
2007年 | 1208篇 |
2006年 | 1078篇 |
2005年 | 1074篇 |
2004年 | 1010篇 |
2003年 | 901篇 |
2002年 | 827篇 |
2001年 | 123篇 |
2000年 | 100篇 |
1999年 | 130篇 |
1998年 | 151篇 |
1997年 | 118篇 |
1996年 | 112篇 |
1995年 | 110篇 |
1994年 | 80篇 |
1993年 | 72篇 |
1992年 | 64篇 |
1991年 | 51篇 |
1990年 | 60篇 |
1989年 | 49篇 |
1988年 | 40篇 |
1987年 | 36篇 |
1986年 | 37篇 |
1985年 | 40篇 |
1984年 | 39篇 |
1983年 | 43篇 |
1982年 | 35篇 |
1981年 | 23篇 |
1980年 | 20篇 |
1979年 | 28篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 10篇 |
1974年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
181.
Prevention of ovarian cancer: intraepithelial neoplasia. 总被引:3,自引:0,他引:3
Molly A Brewer Karen Johnson Michele Follen David Gershenson Robert Bast 《Clinical cancer research》2003,9(1):20-30
To reduce the incidence and mortality associated with invasive cancers, the Intraepithelial Neoplasia (IEN) Task Force recommends that carcinogenesis be viewed as a disease that requires treatment. This publication outlines the current knowledge of IEN of the ovary and reviews chemoprevention possibilities for ovarian cancer. Ovarian cancer has the highest mortality of all of the gynecological cancers and is the fourth leading cause of death from cancer in women. The IEN Task Force has defined precancer as a noninvasive lesion that has genetic abnormalities, loss of cellular control functions, and some phenotypic characteristics of invasive cancer with a substantial likelihood of developing invasive cancer. The IEN Task Force recommends targeting moderate to severe dysplasia for new IEN treatment agents in clinical trials. Ovarian cancer does not have a clear preinvasive lesion yet merits considerable study for new prevention strategies because of the high mortality associated with ovarian cancer. There is a great unmet clinical need for treatments that can prevent ovarian cancer by providing nonsurgical options that treat the entire epithelial layer. New prevention strategies hold significant promise to reduce the mortality from ovarian cancer. 相似文献
182.
Petra Heinm?ller Christof Gross Kurt Beyser Claudia Schmidtgen Gerd Maass Michele Pedrocchi Josef Rüschoff 《Clinical cancer research》2003,9(14):5238-5243
PURPOSE: For the first time a large number (563) of non-small cell lung cancer (NSCLC) samples was used to compare three different technologies for the assessment of HER2 status. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) were used for tumor tissue samples, and ELISA for serum samples. The results were compared with other tumor entities, mainly breast. EXPERIMENTAL DESIGN: Samples (563) from patients suffering from primary advanced or metastatic NSCLC were evaluated. RESULTS: HER2 overexpression was demonstrated using IHC in 20% (83 of 410) of the specimens, whereas 2% (7 of 378) were positive by FISH and 6% (31 of 511) showed elevated serum HER2 levels (>15 ng/ml) by ELISA. Sixty-six specimens were positive by IHC only and 13 by ELISA only, whereas none of the specimens was positive only by FISH. Concordance between all of the techniques was seen for only 3 specimens. Of 7 IHC 3+ specimens, 4 showed gene amplification by FISH, and 3 were positive by ELISA (>15 ng/ml), whereas of 76 IHC 2+ cases only 2 were amplified by FISH, and 4 were positive by ELISA. HER2 positivity by at least one of the three techniques was most common in adenocarcinomas, at 29% (42 of 143). CONCLUSION: Gene amplification and HER2 protein overexpression at the 3+ level appear to be uncommon in NSCLC. The concordance between FISH and IHC 3+ disease was good in this study, in addition, ELISA would have detected several patients without IHC/FISH-positive disease. 相似文献
183.
184.
Michele Iester Andrea Perdicchi Gianmaria Venturino Maurizio Rolando Carlo E Traverso Elvio Leonardi Giovanni Calabria 《Journal of ocular pharmacology and therapeutics》2004,20(5):393-400
PURPOSE: A drug utilization trial was performed to investigate acute versus short-term effects after switching or adding bimatoprost in open-angle glaucoma patients over a 3- month observation period. METHODS: One (1) eye was randomly chosen from 47 glaucomatous patients (abnormal visual field and/or abnormal optic nerve and intraocular pressure (IOP) above 21 mmHg without treatment). Only patients who did not reach the target IOP with their ongoing treatment were recruited in this study. IOP was measured at baseline, after 1 hour, and 2 hours from the first instillation and after 1 week, 1, and 3 months of treatment. RESULTS: The IOP before bimatoprost administration was 20.16+/-3.6 mmHg (mean+/-standard deviation). There was no statistically significant decrease of IOP after 1 hour (mean IOP, 19.96+/-4.25 mmHg) and after 2 hours (mean IOP, 17.73+/-3.24 mmHg). Statistically significant (p<0.001) decreases after 1 week (mean IOP, 16.48+/-2.9 mmHg), after 1 month (mean IOP, 16.48+/-2.9 mmHg) and after 3 months (mean IOP, 16.15+/-2.7 mmHg) were found. CONCLUSION: The results suggested that bimatroprost had a significant acute effect on IOP in monotherapy, while no significant effect was found when the therapy was switched or added. The effect for primary open-angle glaucoma was very evident. There was no specific side effect attributable to combining bimatoprost with any of the treatments in use. 相似文献
185.
Implementation models, such as the national Put Prevention Into Practice program, have produced small to moderate changes in the delivery of preventive services in primary care. More recently, researchers concluded that guides and tools, such as the PPIP toolkit, are helpful, but are not sufficient to facilitate substantive change in clinical preventive practice. Successful implementation of clinical preventive services, according to the Texas Department of Health-PPIP (TDH-PPIP) initiative, involves creating or altering systems to produce change in service delivery for a specific setting. This article describes the ways in which the guidelines and instruments that were developed and refined through the collaborative efforts among public and private health systems were used to implement systems change and improve clinical preventive services at one community primary health care clinic in Texas. The process and empirical results of using the TDH-PPIP Implementation Model in the field are also presented, as well as a discussion of one-year evaluation data. 相似文献
186.
Dejana Selenic Francisco Alvarado-Ramy Mathew Arduino Stacey Holt Fred Cardinali Benjamin Blount Jeff Jarrett Forrest Smith Neil Altman Charlotte Stahl Adelisa Panlilio Michele Pearson Jerome Tokars 《Infection control and hospital epidemiology》2004,25(3):256-261
OBJECTIVE: To determine the cause of acute illness on August 30, 2000, among patients at an outpatient dialysis center (center A). DESIGN: We performed a cohort study of all patients receiving dialysis on August 30, 2000; reviewed dialysis procedures; and analyzed dialysis water samples using microbiologic and chemical assays. SETTING: Dialysis center (center A). PATIENTS: A case-patient was defined as a patient who developed chills within 5 hours after starting hemodialysis at center A on August 30, 2000. RESULTS: Sixteen (36%) of 44 patients at center A met the case definition. All case-patients were hospitalized; 2 died. Besides chills, 15 (94%) of the case-patients experienced nausea; 12 (75%), vomiting; and 4 (25%), fever. Illness was more frequent on the second than the first dialysis shift (16 of 20 vs 0 of 24, P < .001); no other risk factors were identified. The center's water treatment system had received inadequate maintenance and disinfection and a sulfurous odor was noted during sampling of the water from the reverse osmosis (RO) unit. The water had elevated bacterial counts. Volatile sulfur-containing compounds (ie, methanethiol, carbon disulfide, dimethyldisulfide, and sulfur dioxide) were detected by gas chromatography and mass spectrometry in 8 of 12 water samples from the RO unit and in 0 of 28 samples from other areas (P < .001). Results of tests for heavy metals and chloramines were within normal limits. CONCLUSIONS: Parenteral exposure to volatile sulfur-containing compounds, produced under anaerobic conditions in the RO unit, could have caused the outbreak. This investigation demonstrates the importance of appropriate disinfection and maintenance of water treatment systems in hemodialysis centers. 相似文献
187.
Ludovica Segat Michele Milanese Michele Boniotto Sergio Crovella Maria Bernardon Monica Costantini Salvatore Alberico 《The journal of maternal-fetal & neonatal medicine》2006,19(1):13-16
OBJECTIVE: In our study we evaluated the frequency of three SNPs (-52 G/A, -44 C/G; -20 G/A) in the 5' UTR of DEFB-1 gene, in a cohort of 130 HIV-1 infected mothers and their children, collected by the Italian group SIGO in Obstetrics and Gynecology. METHODS: The three SNPs (-52 G/A, -44 C/G; -20 G/A) in the 5' UTR of DEFB-1 gene were genotyped by direct sequencing of PCR products. RESULTS: The C allele at position -44 was shown to be significantly different in both HIV-1 positive mothers and their children when compared to the healthy controls. The odds ratio for -44 C allele in children born to HIV-1 infected mothers is 7.09 (confidence interval 3.38-15.3) while the odds ratio for this allele in HIV-1 infected mothers is 6.42 (confidence interval 3.14-13.4). CONCLUSIONS: Our results evidence a high frequency of the -44 CC allele in HIV-1 infected mothers and their children with augmented potential risk of maternal fetal transmission. This potential vertical transmission risk has been successfully prevented by antiretroviral drug treatment and cesarian section of the HIV-1 positive mothers. 相似文献
188.
Palmiero Monteleone Michele Fabrazzo Mario Maj 《Neuropsychopharmacology》2005,30(9):1769; author reply 1770-1769; author reply 1771
189.
190.
Luis F Porrata Morie A Gertz Mark R Litzow Martha Q Lacy Angela Dispenzieri David J Inwards Stephen M Ansell Ivanna N M Micallef Dennis A Gastineau Michele Elliott William J Hogan Suzanne R Hayman Ayalew Tefferi Svetomir N Markovic 《Clinical cancer research》2005,11(3):1210-1218
PURPOSE: Absolute lymphocyte count recovery at day 15 (ALC-15) post-autologous stem cell transplantation (ASCT) is a powerful prognostic indicator for survival for multiple hematologic malignancies and metastatic breast cancer. The relationship of ALC-15 with clinical outcomes in primary systemic amyloidosis is unknown. EXPERIMENTAL DESIGN: We evaluated 145 consecutive patients with primary systemic amyloidosis who underwent ASCT at the Mayo Clinic from 1996 to 2003. The ALC-15 threshold was set at 500 cells/microL based on our previous observations. RESULTS: The median patient follow-up was 22 months (range, 3-87 months). Higher hematologic complete response was observed in patients with an ALC-15 > or = 500 cells/microL compared with patients with an ALC-15 < 500 cells/microL (41% versus 21%, P < 0.0008, respectively). The median overall survival and progression-free survival times were significantly better for the 59 patients that achieved an ALC-15 > or = 500 cells/microL compared with 86 patients with ALC-15 < 500 cells/microL (not reached versus 53 months, P < 0.0003 and not reached versus 27 months, P < 0.0001, respectively). Multivariate analysis showed ALC-15 to be an independent prognostic factor for overall survival and progression-free survival. CONCLUSIONS: ALC-15 > or = 500 cells/microL is associated with significantly improved clinical outcomes following ASCT in patients with primary systemic amyloidosis. 相似文献